CVE-2023-50345
MEDIUMCVSS 6.1/10EPSS 0.26%
Last modified
CVE-2023-50345 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security threats. . EPSS estimates a 0.26% chance of exploitation in the next 30 days.
Description
HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security threats.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Hcltech | Dryice Myxalytics | 5.9 |
| Hcltech | Dryice Myxalytics | 6.0 |
| Hcltech | Dryice Myxalytics | 6.1 |
References
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-50345?
HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security threats.
How severe is CVE-2023-50345?
CVE-2023-50345 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.26% probability of exploitation in the next 30 days.
How do I fix CVE-2023-50345?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-50345?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST